A survey of emergency physicians' prescription of piperacillin/tazobactam.

IF 1.2 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Sofie Damgaard Mortensen, Sanne Schjødt, Marianne Lisby
{"title":"A survey of emergency physicians' prescription of piperacillin/tazobactam.","authors":"Sofie Damgaard Mortensen, Sanne Schjødt, Marianne Lisby","doi":"10.61409/A11240794","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Piperacillin/tazobactam (Pip/Taz) is a broad-spectrum antibiotic, often prescribed in emergency departments (EDs). Excessive use of broad-spectrum antibiotics may lead to the rise of antimicrobial resistance, a concerning health issue. We investigated physicians' adherence to regional guidelines and their considerations when prescribing Pip/Taz in the ED.</p><p><strong>Methods: </strong>In this cross-sectional survey, a ten-item survey questionnaire was administered to ED physicians in five EDs from 10 January to 7 February 2024.</p><p><strong>Results: </strong>A total of 261 physicians employed in the ED were invited to participate in the survey. Among these, 144 physicians completed the survey, yielding a response rate of 55.2%. Based on the results, 25% were unaware of the regional guidelines on the prescription of Pip/Taz. In addition, over the past month, 25% had prescribed Pip/Taz in situations where regional guidelines recommended a narrow-spectrum antibiotic, primarily because of concerns regarding the patient's condition (74.3%); 30.6% of those who deviated from guidelines were consultants.</p><p><strong>Conclusions: </strong>This study found that a fourth of physicians in EDs were unaware of regional guidelines for prescribing Pip/Taz. Moreover, one in every four physicians purposely deviated from the recommended type of antibiotics, mainly because of concerns about the patient's clinical condition.</p><p><strong>Funding: </strong>None.</p><p><strong>Trial registration: </strong>Not relevant.</p>","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":"72 10","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61409/A11240794","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Piperacillin/tazobactam (Pip/Taz) is a broad-spectrum antibiotic, often prescribed in emergency departments (EDs). Excessive use of broad-spectrum antibiotics may lead to the rise of antimicrobial resistance, a concerning health issue. We investigated physicians' adherence to regional guidelines and their considerations when prescribing Pip/Taz in the ED.

Methods: In this cross-sectional survey, a ten-item survey questionnaire was administered to ED physicians in five EDs from 10 January to 7 February 2024.

Results: A total of 261 physicians employed in the ED were invited to participate in the survey. Among these, 144 physicians completed the survey, yielding a response rate of 55.2%. Based on the results, 25% were unaware of the regional guidelines on the prescription of Pip/Taz. In addition, over the past month, 25% had prescribed Pip/Taz in situations where regional guidelines recommended a narrow-spectrum antibiotic, primarily because of concerns regarding the patient's condition (74.3%); 30.6% of those who deviated from guidelines were consultants.

Conclusions: This study found that a fourth of physicians in EDs were unaware of regional guidelines for prescribing Pip/Taz. Moreover, one in every four physicians purposely deviated from the recommended type of antibiotics, mainly because of concerns about the patient's clinical condition.

Funding: None.

Trial registration: Not relevant.

急诊医师哌拉西林/他唑巴坦处方调查。
简介:哌拉西林/他唑巴坦(Pip/Taz)是一种广谱抗生素,常用于急诊科(EDs)。过度使用广谱抗生素可能导致抗菌素耐药性上升,这是一个令人关切的健康问题。我们调查了医生对地区指南的依从性以及他们在ED处方Pip/Taz时的考虑。方法:在这项横断面调查中,从2024年1月10日至2月7日,对5个ED医生进行了一份10项调查问卷。结果:共有261名在急诊科工作的医生参与了调查。其中144名医生完成了调查,回复率为55.2%。根据结果,25%的人不知道Pip/Taz处方的区域指南。此外,在过去一个月里,25%的医生在区域指南建议使用窄谱抗生素的情况下开了Pip/Taz,主要是因为担心患者的病情(74.3%);30.6%偏离指南的是咨询师。结论:本研究发现急诊科四分之一的医生不知道开具Pip/Taz处方的地区指南。此外,四分之一的医生故意偏离推荐的抗生素类型,主要是因为担心患者的临床状况。资金:没有。试验注册:不相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Danish medical journal
Danish medical journal MEDICINE, GENERAL & INTERNAL-
CiteScore
2.30
自引率
6.20%
发文量
78
审稿时长
3-8 weeks
期刊介绍: The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content. DMJ will publish the following articles: • Original articles • Protocol articles from large randomized clinical trials • Systematic reviews and meta-analyses • PhD theses from Danish faculties of health sciences • DMSc theses from Danish faculties of health sciences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信